The epithelioid sarcoma market is estimated to be valued at USD 1.57 Bn in 2025 and is expected to reach USD 2.93 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032. https://timessquarereporter.com/news/epithelioid-sarcoma-market-to-show-growth-with-targeted-ezh2-inhibitors